BioTime Company Profile (NYSEMKT:BTX)

About BioTime

BioTime logoBioTime, Inc. is a clinical-stage biotechnology company. The Company is focused on the field of regenerative medicine, specifically pluripotent stem cell technology. The Company is engaged in the research and development of therapeutic products for oncology, orthopedics, retinal and neurological diseases and disorders, blood and vascular system diseases and disorders, blood plasma volume expansion, diagnostic products for the early detection of cancer, and hydrogel products that may be used in surgery and products for human embryonic stem cell research. Regenerative medicine refers to therapies based on stem cell technology that are designed to rebuild cell and tissue function lost due to degenerative disease or injury. The Company's pluripotent stem cell technology is complemented by its HyStem technology for the delivery and engraftment of cells, whether derived from pluripotent stem cells or the patient's own somatic or adult stem cells, at the desired location.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NYSEMKT
  • Symbol: BTX
  • CUSIP: 09066L10
Key Metrics:
  • Previous Close: $3.14
  • 50 Day Moving Average: $3.05
  • 200 Day Moving Average: $2.78
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.14
  • P/E Growth: 0.00
  • Market Cap: $319.23M
  • Outstanding Shares: 101,667,000
  • Beta: 1.37
Additional Links:
Companies Related to BioTime:

Analyst Ratings

Consensus Ratings for BioTime (NYSEMKT:BTX) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $7.50

Analysts' Ratings History for BioTime (NYSEMKT:BTX)
Show:
DateFirmActionRatingPrice TargetDetails
4/7/2016Chardan CapitalInitiated CoverageBuyView Rating Details
4/2/2016Oppenheimer Holdings Inc.Reiterated RatingBuyView Rating Details
(Data available from 8/24/2014 forward)

Earnings

Earnings History for BioTime (NYSEMKT:BTX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/9/2016Q216($0.17)$0.26$1.75 million$1.27 millionViewN/AView Earnings Details
5/10/2016Q116($0.14)($0.19)$1.43 million$2.10 millionViewN/AView Earnings Details
3/9/2016Q4($0.17)($0.16)ViewN/AView Earnings Details
5/11/2015Q115($0.13)$1.10 million$1.30 millionViewN/AView Earnings Details
11/10/2014Q314($0.12)$1.20 millionViewN/AView Earnings Details
8/12/2014Q214($0.16)$362.25 million$300.08 millionViewN/AView Earnings Details
5/12/2014Q114($0.14)$0.61 million$1.07 millionViewN/AView Earnings Details
11/12/2013Q3($0.16)ViewN/AView Earnings Details
3/18/2013Q412($0.12)$1.70 million$1.20 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for BioTime (NYSEMKT:BTX)
Current Year EPS Consensus Estimate: $-0.26 EPS
Next Year EPS Consensus Estimate: $-0.44 EPS

Dividends

Dividend History for BioTime (NYSEMKT:BTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for BioTime (NYSEMKT:BTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/21/2016Broadwood Partners LpDirectorBuy2,732,636$2.39$6,531,000.04View SEC Filing  
1/20/2016Broadwood Partners LpDirectorBuy300,000$2.35$705,000.00View SEC Filing  
11/6/2015Alfred D KingsleyInsiderSell100,000$3.83$383,000.00View SEC Filing  
11/6/2015Stephen C FarrellDirectorBuy50,000$3.83$191,500.00View SEC Filing  
8/26/2015Deborah J AndrewsDirectorBuy2,000$2.82$5,640.00View SEC Filing  
8/18/2015Stephen Lahue CarttDirectorBuy75,000$2.80$210,000.00View SEC Filing  
10/8/2014David SchlachetDirectorBuy32,050$3.12$99,996.00View SEC Filing  
7/22/2014Broadwood Partners LpDirectorBuy370,000$2.65$980,500.00View SEC Filing  
7/22/2014Michael D WestCEOSell270,000$2.65$715,500.00View SEC Filing  
7/22/2014Robert PeabodyCFOSell100,000$2.65$265,000.00View SEC Filing  
6/17/2014William P Phd TewInsiderSell30,000$3.07$92,100.00View SEC Filing  
6/16/2014Broadwood Partners LpDirectorBuy1,000,000$2.50$2,500,000.00View SEC Filing  
5/16/2014Broadwood Partners LpDirectorBuy300,000$2.45$735,000.00View SEC Filing  
5/8/2014Broadwood Partners LpDirectorBuy300,000$2.44$732,000.00View SEC Filing  
5/1/2014Broadwood Partners LpDirectorBuy2,000,000$2.52$5,040,000.00View SEC Filing  
2/25/2014Broadwood Partners LpDirectorBuy500,000$3.74$1,870,000.00View SEC Filing  
12/30/2013Neal C BradsherDirectorBuy300,042$3.51$1,053,147.42View SEC Filing  
11/20/2013William P Phd TewInsiderSell13,860$3.76$52,113.60View SEC Filing  
9/12/2013Stephen C FarrellDirectorBuy11,213$3.89$43,618.57View SEC Filing  
8/20/2013Stephen C FarrellDirectorBuy4,187$3.65$15,282.55View SEC Filing  
8/12/2013Eschenbach Andrew C VonDirectorBuy3,000$3.69$11,070.00View SEC Filing  
3/28/2013Broadwood Partners LpDirectorBuy200,000$3.81$762,000.00View SEC Filing  
11/15/2012Broadwood Partners LpDirectorBuy344,828$2.90$1,000,001.20View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for BioTime (NYSEMKT:BTX)
DateHeadline
kcregister.com logoStocks to Watch: Cerulean Pharma Inc. (NASDAQ:CERU), BioTime, Inc. (NYSE:BTX), Pfizer Inc. (NYSE:PFE ... - KC Register (NYSEMKT:BTX)
www.kcregister.com - August 23 at 8:08 AM
finance.yahoo.com logoBIOTIME INC Financials (NYSEMKT:BTX)
finance.yahoo.com - August 18 at 4:10 PM
News IconContango ORE, Inc. Announces Recent Drilling Results (NYSEMKT:BTX)
www.onenewspage.com - August 16 at 4:04 PM
finance.yahoo.com logo8:01 am BioTime announces the issuance of 31 new patents (NYSEMKT:BTX)
finance.yahoo.com - August 15 at 11:13 AM
publicnow.com logoBioTime Announces Issuance of 31 New Patents to Strengthen its Patent Portfolio in Regenerative Medicine (NYSEMKT:BTX)
www.publicnow.com - August 15 at 11:13 AM
capitalcube.com logoETF’s with exposure to BioTime, Inc. : August 15, 2016 (NYSEMKT:BTX)
www.capitalcube.com - August 15 at 11:13 AM
capitalcube.com logoBioTime, Inc. :BTX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NYSEMKT:BTX)
www.capitalcube.com - August 12 at 3:28 PM
kcregister.com logoNews Buzz: BioTime, Inc. (NYSE:BTX), Micronet Enertec Technologies, Inc. (NASDAQ:MICT), Evolving Systems ... - KC Register (NYSEMKT:BTX)
www.kcregister.com - August 11 at 4:05 PM
cnbc.com logoBioTime posts 2Q profit (NYSEMKT:BTX)
www.cnbc.com - August 9 at 10:34 PM
biz.yahoo.com logoQ2 2016 BioTime Inc Earnings Release - After Market Close (NYSEMKT:BTX)
biz.yahoo.com - August 9 at 12:55 PM
istreetwire.com logoTrader's Buzzers: Fidelity National Financial, Inc. (FNF), BioTime, Inc. (BTX), Fair Isaac Corporation (FICO) - iStreetWire (NYSEMKT:BTX)
istreetwire.com - July 30 at 2:10 PM
kcregister.com logoToday's Hot List: BioTime, Inc. (NYSE:BTX), Robert Half International (NYSE:RHI), Duke Realty Corporation (NYSE ... - KC Register (NYSEMKT:BTX)
www.kcregister.com - July 28 at 12:44 PM
businesswire.com logoBioTime, Inc. to Report Second Quarter Results on August 9, 2016 ... - Business Wire (press release) (NYSEMKT:BTX)
www.businesswire.com - July 27 at 9:44 PM
finance.yahoo.com logoBioTime, Inc. to Report Second Quarter Results on August … (NYSEMKT:BTX)
finance.yahoo.com - July 27 at 12:32 PM
publicnow.com logoBioTime, Inc. to Report Second Quarter Results on August 9, 2016 (NYSEMKT:BTX)
www.publicnow.com - July 27 at 9:08 AM
news.cmlviz.com logoBioTime Inc (AMEX:BTX) Stock Volatility Hits An Unsually High Level - CML News (NYSEMKT:BTX)
news.cmlviz.com - July 21 at 4:04 PM
capitalcube.com logoETF’s with exposure to BioTime, Inc. : July 21, 2016 (NYSEMKT:BTX)
www.capitalcube.com - July 21 at 1:50 PM
News IconBiotime Incorporated (NYSEMKT:BTX) Shorts Decreased by 26.35% After Short Covering - Consumer Eagle (NYSEMKT:BTX)
www.consumereagle.com - July 20 at 5:03 PM
News IconIncreased Stock Volatility Watch: BioTime, Inc. (:BTX) - Engelwood Daily (NYSEMKT:BTX)
www.engelwooddaily.com - July 20 at 5:03 PM
News IconCorporate Document-Investor Presentation for BioTime, Inc. (NYSEMKT:BTX)
www.companyspotlight.com - July 20 at 10:04 AM
News IconBiotime Incorporated (NYSEMKT:BTX) Shorts Decreased by 2.42% After Short Covering - Consumer Eagle (NYSEMKT:BTX)
www.consumereagle.com - July 16 at 3:58 PM
publicnow.com logoLandmark Stem Cell Clinical Trial Procedure Performed at Santa Clara Valley Medical Center (NYSEMKT:BTX)
www.publicnow.com - July 14 at 3:48 PM
News IconBiotime Incorporated (NYSEMKT:BTX) Short Interest Decreased By 2.42% - Consumer Eagle (NYSEMKT:BTX)
www.consumereagle.com - July 14 at 11:32 AM
News IconInsiders Increasing Positions in: BioTime, Inc. (:BTX) - Press Telegraph (NYSEMKT:BTX)
presstelegraph.com - July 14 at 11:32 AM
News IconBiotime Incorporated (NYSEMKT:BTX) Shorts Decreased by 2.42% After Short Covering - Press Telegraph (NYSEMKT:BTX)
presstelegraph.com - July 10 at 3:54 PM
news.cmlviz.com logoBioTime, Inc. Stock Momentum at Critical Inflection Point - CML News (NYSEMKT:BTX)
news.cmlviz.com - July 8 at 11:58 AM
kcregister.com logoToday's Watch List: BioTime, Inc. (NYSEMKT:BTX), Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH), Gran Tierra Energy ... - KC Register (NYSEMKT:BTX)
www.kcregister.com - July 8 at 11:58 AM
News IconStock Tracking Down This Month; Investor Alert on BioTime, Inc. (:BTX) - Engelwood Daily (NYSEMKT:BTX)
www.engelwooddaily.com - July 7 at 3:59 PM
capitalcube.com logoETF’s with exposure to BioTime, Inc. : July 7, 2016 (NYSEMKT:BTX)
www.capitalcube.com - July 7 at 2:46 PM
biz.yahoo.com logoBIOTIME INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NYSEMKT:BTX)
biz.yahoo.com - July 5 at 5:23 PM
businesswire.com logoBioTime, Inc. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option - Business Wire (press release) (NYSEMKT:BTX)
www.businesswire.com - July 5 at 3:59 PM
publicnow.com logoBioTime, Inc. Announces Full Exercise and Closing of Underwriters’ Over-Allotment Option (NYSEMKT:BTX)
www.publicnow.com - July 5 at 11:51 AM
News IconBiotime Incorporated (NYSEMKT:BTX) Short Interest Decreased By 2.42% - Engelwood Daily (NYSEMKT:BTX)
www.engelwooddaily.com - July 5 at 8:44 AM
4-traders.com logoBioTime : Presents Online Resource for Applying Artificial Intelligence to Stem Cell Biology at Mensa 2016 Annual Gathering (NYSEMKT:BTX)
www.4-traders.com - July 1 at 12:04 PM
News IconBioTime, Inc. Stock Price Increases Today - Engelwood Daily (NYSEMKT:BTX)
www.engelwooddaily.com - June 30 at 9:28 PM
kcregister.com logoMorning Buzz: WPX Energy, Inc. (NYSE:WPX), BioTime, Inc. (NYSEMKT:BTX), Newmont Mining Corporation (NYSE ... - KC Register (NYSEMKT:BTX)
www.kcregister.com - June 30 at 9:28 PM
businesswire.com logoBioTime Presents Online Resource for Applying Artificial Intelligence to Stem Cell Biology at Mensa 2016 Annual ... - Business Wire (press release) (NYSEMKT:BTX)
www.businesswire.com - June 29 at 9:04 PM
publicnow.com logoBioTime Presents Online Resource for Applying Artificial Intelligence to Stem Cell Biology at Mensa 2016 Annual Gathering (NYSEMKT:BTX)
www.publicnow.com - June 29 at 8:21 AM
istreetwire.com logoAnalysts Review: BioTime, Inc. (NYSEMKT:BTX) - iStreetWire (NYSEMKT:BTX)
istreetwire.com - June 26 at 9:10 AM
businesswire.com logoBioTime, Inc. Announces Closing of Public Offering of Common Stock - Business Wire (press release) (NYSEMKT:BTX)
www.businesswire.com - June 22 at 4:08 PM
publicnow.com logoBioTime, Inc. Announces Closing of Public Offering of Common Stock (NYSEMKT:BTX)
www.publicnow.com - June 21 at 12:19 PM
kcregister.com logoHealthcare Unusual Volume: ViewRay, Inc. (NASDAQ:VRAY), BioTime, Inc. (NYSEMKT:BTX), Innocoll Holdings plc ... - KC Register (NYSEMKT:BTX)
www.kcregister.com - June 20 at 10:24 AM
equities.com logoBioTime Inc. (BTX) Drops 7.69% on June 16 - Equities.com (NYSEMKT:BTX)
www.equities.com - June 18 at 8:39 AM
News IconBioTime, Inc. (NYSEMKT:BTX) Eyes $17.5 Million IPO - Scibility Media (NYSEMKT:BTX)
scibilitymedia.com - June 17 at 3:51 PM
biz.yahoo.com logoBIOTIME INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NYSEMKT:BTX)
biz.yahoo.com - June 17 at 2:13 PM
streetinsider.com logoBioTime (BTX) Prices 7.3M Stock Offering at $2.39/Share (NYSEMKT:BTX)
www.streetinsider.com - June 16 at 9:19 PM
investorplace.com logoBiggest Movers in Manufacturing Stocks Now – QLGC VBIV BLPH AMD - Investorplace.com (NYSEMKT:BTX)
investorplace.com - June 16 at 3:57 PM
streetinsider.com logoBioTime (BTX) Prices 7.3M Stock Offering at $2.39/Share - StreetInsider.com (NYSEMKT:BTX)
www.streetinsider.com - June 16 at 3:57 PM
insidermonkey.com logoA Look at Five Stocks that Are Trending on Thursday (NYSEMKT:BTX)
www.insidermonkey.com - June 16 at 12:08 PM
publicnow.com logoBioTime, Inc. Announces Pricing of Public Offering of Common Stock (NYSEMKT:BTX)
www.publicnow.com - June 16 at 10:39 AM

Social


Last Updated on 8/24/2016 by MarketBeat.com Staff